Online citations, reference lists, and bibliographies.
Referencing for people who value simplicity, privacy, and speed.
Get Citationsy
← Back to Search

A High Cell Density Transient Transfection System For Therapeutic Protein Expression Based On A CHO GS‐knockout Cell Line: Process Development And Product Quality Assessment

Yashas Rajendra, Maria D Hougland, Riazul Alam, Teresa A Morehead, Gavin C. Barnard
Published 2015 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Transient gene expression (TGE) is a rapid method for the production of recombinant proteins in mammalian cells. While the volumetric productivity of TGE has improved significantly over the past decade, most methods involve extensive cell line engineering and plasmid vector optimization in addition to long fed batch cultures lasting up to 21 days. Our colleagues have recently reported the development of a CHO K1SV GS‐KO host cell line. By creating a bi‐allelic glutamine synthetase knock out of the original CHOK1SV host cell line, they were able to improve the efficiency of generating high producing stable CHO lines for drug product manufacturing. We developed a TGE method using the same CHO K1SV GS‐KO host cell line without any further cell line engineering. We also refrained from performing plasmid vector engineering. Our objective was to setup a TGE process to mimic protein quality attributes obtained from stable CHO cell line. Polyethyleneimine (PEI)‐mediated transfections were performed at high cell density (4 × 106 cells/mL) followed by immediate growth arrest at 32°C for 7 days. Optimizing DNA and PEI concentrations proved to be important. Interestingly, found the direct transfection method (where DNA and PEI were added sequentially) to be superior to the more common indirect method (where DNA and PEI are first pre‐complexed). Moreover, the addition of a single feed solution and a polar solvent (N,N dimethylacetamide) significantly increased product titers. The scalability of process from 2 mL to 2 L was demonstrated using multiple proteins and multiple expression volumes. Using this simple, short, 7‐day TGE process, we were able to successfully produce 54 unique proteins in a fraction of the time that would have been required to produce the respective stable CHO cell lines. The list of 54 unique proteins includes mAbs, bispecific antibodies, and Fc‐fusion proteins. Antibody titers of up to 350 mg/L were achieved with the simple 7‐day process. Titers were increased to 1 g/L by extending the culture to 16 days. We also present two case studies comparing product quality of material generated by transient HEK293, transient CHO K1SV GS‐KO, and stable CHO K1SV KO pool. Protein from transient CHO was more representative of stable CHO protein compared to protein produced from HEK293. Biotechnol. Bioeng. 2015;112: 977–986. © 2014 Wiley Periodicals, Inc.
This paper references
transfection condition optimization. Protein Expr Purif
AB Bos (2014)
Transient expression of an IL23R extracellular domain Fc fusion protein in CHO vs
KF Suen (2010)
A simple high-yielding
Y 5075epfl-thesis-5572 Rajendra (2011)
Production technologies for monoclonal antibodies and their fragments.
D. Andersen (2004)
day) and stable CHO pool (14 day) were subject to analytical SEC analysis as described in method section. Presence and absence of HC dimer is indicated in the figure
Transient expression of an IL-23R extracellular domain Fc fusion protein in CHO vs. HEK cells results in improved plasma exposure.
K. Suen (2010)
A high‐yielding CHO transient system: Coexpression of genes encoding EBNA‐1 and GS enhances transient protein expression
O. Daramola (2014)
Recombinant protein production by transient gene transfer into Mammalian cells.
S. Geisse (2009)
A Simple High Yielding Transient Gene Expression System for CHO Cells
Y. Rajendra (2013)
DNA in reducing coding DNA requirement for transient gene expression with CHO and HEK293E cells
C Raymond (2011)
Mammalian cells. Method Enzymol
A Kichler (2005)
Recombinant protein production by large-scale transient gene expression in mammalian cells: state of the art and future perspectives
L. Baldi (2006)
A CHO cell line engineered to express XBP1 and ERO1‐Lα has increased levels of transient protein expression
Katharine Cain (2013)
Comparison of SEC profile for three mAb variants from transient HEK293, stable CHO pool and transient CHO
Production of recombinant protein therapeutics in cultivated mammalian cells
F. Wurm (2004)
Biopharmaceutical benchmarks 2010. Nat Biotechnol 28:917–924
G. 96–102. Walsh (2010)
Large-scale transfection of mammalian cells.
L. Baldi (2012)
Reflections on more than 10 years of TGE approaches.
S. Geisse (2009)
A simplified polyethylenimine-mediated transfection process for large-scale and high-throughput applications.
C. Raymond (2011)
Role of non - speci fi c DNA in reducing coding DNA requirement for transient gene expression with CHO and HEK - 293 E cells
C Raymond
Mammalian cell protein expression for biopharmaceutical production.
J. Zhu (2012)
Junk DNA enhances pEI-based non-viral gene delivery.
E. V. van Gaal (2010)
Biopharmaceutical benchmarks 2010
G. Walsh (2010)
Development of a highly-efficient CHO cell line generation system with engineered SV40E promoter.
L. Fan (2013)
Use of an anti‐apoptotic CHO cell line for transient gene expression
Nichole Macaraeg (2013)
Microtiter plates as mini-bioreactors: miniaturization of fermentation methods.
W. Duetz (2007)
Improving the efficiency of CHO cell line generation using glutamine synthetase gene knockout cells
L. Fan (2012)
Development of a semi-automated high throughput transient transfection system.
A. B. Bos (2014)
Dilution of reporter gene with stuffer DNA does not alter the transfection efficiency of polyethylenimines
A. Kichler (2005)
A simple high-yielding process for transient gene expression in CHO cells.
Y. Rajendra (2011)
Recombinant protein expression for therapeutic applications.
D. Andersen (2002)
Large-Scale transfection of mammalian cells for the fast production of recombinant protein
P. L. Pham (2006)
High-density transfection with HEK-293 cells allows doubling of transient titers and removes need for a priori DNA complex formation with PEI.
G. Backliwal (2008)
Accepted Preprint This article is protected by copyright. All rights reserved
Rational vector design and multi-pathway modulation of HEK 293E cells yield recombinant antibody titers exceeding 1 g/l by transient transfection under serum-free conditions
G. Backliwal (2008)
Enhanced transient recombinant protein production in CHO cells through the co‐transfection of the product gene with Bcl‐xL
Matthew P Zustiak (2014)
Design of Experiment in CHO and HEK transient transfection condition optimization.
Frederic Bollin (2011)
Differences in the glycosylation of recombinant proteins expressed in HEK and CHO cells.
Amélie Croset (2012)
Role of non‐specific DNA in reducing coding DNA requirement for transient gene expression with CHO and HEK‐293E cells
Y. Rajendra (2012)
Transient recombinant protein expression in a human amniocyte cell line: The CAP‐T® cell system
Simon Fischer (2012)
transient protein expression
I Kadura (2007)

This paper is referenced by
Generation of High Expressing Chinese Hamster Ovary Cell Pools Using the Leap-In Transposon System.
Sowmya Balasubramanian (2018)
Expression Systems for Recombinant Biopharmaceutical Production by Mammalian Cells in Culture
A. Brown (2017)
Advancements in mammalian cell transient gene expression (TGE) technology for accelerated production of biologics
Sonia Gutiérrez-Granados (2018)
The transient expression of CHIKV VLP in large stirred tank bioreactors
Peifeng Chen (2019)
Beyond preclinical research: production of CHO-derived biotherapeutics for toxicology and early-phase trials by transient gene expression or stable pools
Matthew Stuible (2018)
Enhanced plasmid DNA utilization in transiently transfected CHO–DG44 cells in the presence of polar solvents
Y. Rajendra (2015)
Comparison of three transposons for the generation of highly productive recombinant CHO cell pools and cell lines
S. Balasubramanian (2016)
Transient Gene Expression‐Based Protein Production in Recombinant Mammalian Cells
Joohyoung Lee (2019)
Enhanced Production of Anti-PD1 Antibody in CHO Cells through Transient Co-Transfection with Anti-Apoptotic Gene Bcl-xL Combined with Rapamycin
Yunxia Li (2019)
High cell density transient transfection of CHO cells for TGF‐β1 expression
A. El-Shereef (2019)
Rapid high-throughput cloning and stable expression of antibodies in HEK293 cells.
Jared L Spidel (2016)
Transcriptional and post-transcriptional targeting for enhanced transient gene expression in CHO cells
Y. Rajendra (2015)
A Novel Artificially Humanized Anti-Cripto-1 Antibody Suppressing Cancer Cell Growth
Hiroko Ishii (2021)
A high density CHO-S transient transfection system: Comparison of ExpiCHO and Expi293.
Nina K. Jain (2017)
Transient Gene Expression in Suspension HEK293-EBNA1 Cells.
Denis L’Abbé (2018)
Polymer‐mediated flocculation of transient CHO cultures as a simple, high throughput method to facilitate antibody discovery
Matthew G Schmitt (2017)
PEI-Mediated Transient Gene Expression in CHO Cells.
Y. Rajendra (2018)
Development of a high cell density transient CHO platform yielding mAb titers greater than 2 g/L in only 7 days
Matthew G Schmitt (2020)
Anticorps anti-cd9 thérapeutique
Hergen Spits (2017)
Generation of stable Chinese hamster ovary pools yielding antibody titers of up to 7.6 g/L using the piggyBac transposon system
Y. Rajendra (2016)
New Mammalian Expression Systems.
J. Zhu (2018)
Optimization of a high-cell-density polyethylenimine transfection method for rapid protein production in CHO-EBNA1 cells.
Matthew Stuible (2018)
RNase H-dependent PCR enables highly specific amplification of antibody variable domains from single B-cells
J. Crissman (2020)
Cell Line Development for Therapeutic Protein Production
Soo Min Noh (2019)
Enhanced production of anti-PD1 antibody in CHO cells through transient co-transfection with anti-apoptotic genes Bcl-xL and Mcl-1
X. Zhang (2018)
Transient CHO expression platform for robust antibody production and its enhanced N‐glycan sialylation on therapeutic glycoproteins
X. Zhong (2019)
Transient and stable CHO expression, purification and characterization of novel hetero‐dimeric bispecific IgG antibodies
Y. Rajendra (2017)
Computational design of a specific heavy chain/κ light chain interface for expressing fully IgG bispecific antibodies
K. J. Froning (2017)
Protein Production in Eukaryotic Cells
K. Ram (2016)
[Biomanufacturing of monoclonal antibodies].
S. Joubert (2019)
Development of an alternating tangential flow (ATF) perfusion‐based transient gene expression (TGE) bioprocess for universal influenza vaccine
Jinsung Hong (2019)
Co-amplification of EBNA-1 and PyLT through dhfr-mediated gene amplification for improving foreign protein production in transient gene expression in CHO cells
J. Lee (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar